Investor · Houston, TX
Scott A. Jordan
Open Scott in the network graph →Capital
$1.7M
across filings
Active
May 2019
to May 2021
Most-connected co-filers (25)
Jonathan P. Northrup · Houston, TX7 sharedSunil P. Sharma · Houston, TX7 sharedJohn J. Schreiber · Boston, MA3 sharedWilliam S. Seybold · San Francisco, CA3 sharedPhilip D. Dreyfuss · San Francisco, CA3 sharedGarth D. Ebanks · Grand Cayman, Cayman Islands3 shared325 Capital LLC · NEW YORK, NY3 sharedJoseph T. Phoenix · Boston, MA3 sharedDan Frawley · Boulder, CO3 sharedEric Westerkamp · Boulder, CO3 sharedMike G. Koziol · Val Caron, Ontario, Canada3 sharedCharles-Henri Clerget · Boston, MA2 sharedDoug A. Derwin · San Francisco, CA2 sharedStephanie K. Douglas · Aurora, CO2 sharedDonald Plotsky · Park City, UT2 sharedTiffany Taylor Chen · Austin, TX2 sharedMark T. Melton · Boulder, CO2 sharedMichael Boniello · San Francisco, CA2 sharedDavid J. Ehrlich · San Francisco, CA2 sharedPedro Alves · San Mateo, CA2 sharedSebastien Mannai · Boston, MA2 sharedLouis Creteur · Boston, MA2 sharedKenneth Carter · Gaithersburg, MD1 sharedJoe H. Cunningham · Austin, TX1 shared Recent filings (9)
Stingray Therapeutics, Inc.May 2021 · 8 co-filers$3.0MStingray Therapeutics, Inc.Oct 2020 · 8 co-filers$1.5MStingray Therapeutics, Inc.Aug 2020 · 8 co-filers$1.5MAcoustic Wells, Inc.Feb 2020 · 8 co-filers$3.0MOple, Inc.Oct 2019 · 8 co-filers$17.4MAcoustic Wells, Inc.Jul 2019 · 5 co-filers$2.0MAcoustic Wells, Inc.May 2019 · 8 co-filers$600KOple, Inc.May 2019 · 10 co-filers$13.2MBeta Cat Pharmaceuticals, Inc.Dec 2017 · 9 co-filers$1.4MBeta Cat Pharmaceuticals, Inc.Dec 2017 · 9 co-filers$1.4M Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Scott in the interactive graph →